Commerce Bank acquired a new position in shares of Humana Inc. (NYSE:HUM – Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 3,863 shares of the insurance provider’s stock, valued at approximately $1,534,000.
Several other hedge funds have also recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC acquired a new stake in shares of Humana in the fourth quarter valued at about $202,000. Woodline Partners LP raised its holdings in Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after acquiring an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in Humana by 53.7% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after acquiring an additional 452 shares during the last quarter. Cresset Asset Management LLC boosted its holdings in shares of Humana by 10.3% during the 2nd quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after purchasing an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd boosted its holdings in shares of Humana by 58.5% during the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.
Humana Price Performance
Shares of HUM opened at $388.92 on Wednesday. The firm has a 50-day simple moving average of $383.88 and a two-hundred day simple moving average of $285.00. The stock has a market cap of $46.70 billion, a PE ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74.
Wall Street Analysts Forecast Growth
HUM has been the subject of several recent research reports. Wolfe Research reaffirmed an “outperform” rating and issued a $450.00 price target on shares of Humana in a report on Monday. William Blair assumed coverage on shares of Humana in a report on Wednesday, May 20th. They set an “outperform” rating for the company. TD Cowen lifted their price target on shares of Humana from $350.00 to $370.00 and gave the company a “hold” rating in a research report on Friday, July 31st. Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $227.00 to $502.00 in a research report on Monday, July 13th. Finally, Raymond James Financial cut Humana from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Humana has an average rating of “Hold” and a consensus target price of $403.91.
View Our Latest Stock Report on HUM
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
- Five stocks we like better than Humana
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
